Compare WYFI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WYFI | PHAR |
|---|---|---|
| Founded | 2023 | 1988 |
| Country | United States | Netherlands |
| Employees | 83 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 953.8M | 885.7M |
| IPO Year | N/A | 2020 |
| Metric | WYFI | PHAR |
|---|---|---|
| Price | $44.80 | $12.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $29.20 | ★ $38.33 |
| AVG Volume (30 Days) | ★ 1.7M | 7.2K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $80.46 | $10.04 |
| Revenue Next Year | $89.73 | $2.51 |
| P/E Ratio | ★ N/A | $3,041.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.51 | $9.54 |
| 52 Week High | $46.87 | $21.34 |
| Indicator | WYFI | PHAR |
|---|---|---|
| Relative Strength Index (RSI) | 72.24 | 47.03 |
| Support Level | $14.41 | $11.88 |
| Resistance Level | N/A | $13.61 |
| Average True Range (ATR) | 4.45 | 0.49 |
| MACD | 1.72 | 0.13 |
| Stochastic Oscillator | 88.88 | 66.90 |
Whitefiber Inc is a provider of artificial intelligence infrastructure solutions. The company owns high-performance computing data centers and provide cloud-based HPC graphics processing units services, which it terms cloud services, for customers such as AI application and machine learning developers. Its Tier-3 data centers provide hosting and colocation services. Its cloud services support generative AI workstreams, especially training and inference. It has two reportable segments: cloud services and colocation services. The cloud services segment generates revenue from providing high performance computing services to support generative AI workstreams. Colocation services generate revenue by providing customers with physical space, power and cooling within the data center facility.
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.